Alleviating Drug Shortages: The Role of Mandated Reporting Induced Operational Transparency

References

• Acosta A , Vanegas EP , Rovira J , Godman B , Bochenek T (2019) Medicines shortages: Gaps between countries and global perspectives. Frontiers Pharmacology 10:763.Crossref, Google Scholar
• Adida E , Mamani H , Nassiri S (2016) Bundled payment vs. fee-for-service: Impact of payment scheme on performance. Management Sci. 63(5):1606–1624.Link, Google Scholar
• Batt RJ , Terwiesch C (2015) Waiting patiently: An empirical study of queue abandonment in an emergency department. Management Sci. 61(1):39–59.Link, Google Scholar
• Becker DJ , Talwar S , Levy BP , Thorn M , Roitman J , Blum RH , Harrison LB , Grossbard ML (2013) Impact of oncology drug shortages on patient therapy: Unplanned treatment changes. J. Oncology Practice 9(4):e122–e128.Crossref, Google Scholar
• Bertrand M , Duflo E , Mullainathan S (2004) How much should we trust differences-in-differences estimates? Quart. J. Econom. 119(1):249–275.Crossref, Google Scholar
• Bertrand M , Schoar A , Thesmar D (2007) Banking deregulation and industry structure: Evidence from the French banking reforms of 1985. J. Finance 62(2):597–628.Crossref, Google Scholar
• Blanchard OJ , Lopez-de Silanes F , Shleifer A (1994) What do firms do with cash windfalls? J. Financial Econom. 36(3):337–360.Crossref, Google Scholar
• Buell RW , Kim T , Tsay CJ (2017) Creating reciprocal value through operational transparency. Management Sci. 63(6):1673–1695.Link, Google Scholar
• Bukofzer S , Ayres J , Chavez A , Devera M , Miller J , Ross D , Shabushnig J , Vargo S , Watson H , Watson R (2015) Industry perspective on the medical risk of visible particles in injectable drug products. PDA J. Pharmaceutical Sci. Tech. 69(1):123–139.Crossref, Google Scholar
• Dutt N , King AA (2014) The judgment of garbage: End-of-pipe treatment and waste reduction. Management Sci. 60(7):1812–1828.Link, Google Scholar
• Economist Intelligence Unit (2017) Addressing medicine shortages in Europe. Technical report, The Economist Intelligence Unit, London. http://graphics.eiu.com/upload/topic-pages/medicine-shortages/Addressing-medicine-shortages-in-Europe-EIU.pdf.Google Scholar
• Farris P , Olver J , De Kluyver C (1989) The relationship between distribution and market share. Marketing Sci. 8(2):107–128.Link, Google Scholar
• Fink S (2016) Drug shortages forcing hard decisions on rationing treatments. New York Times (January 29), https://www.nytimes.com/2016/01/29/drug-shortages-forcing-hard-decisions-on-rationing-treatments.html.Google Scholar
• Fisher ML , Gallino S , Xu JJ (2019) The value of rapid delivery in omnichannel retailing. J. Marketing Res. 56(5):732–748.Crossref, Google Scholar
• Fox ER , Tyler LS (2003) Managing drug shortages: Seven years’ experience at one health system. Amer. J. Health System Pharmacy 60(3):245–253.Crossref, Google Scholar
• Fox ER , Sweet BV , Jensen V (2014) Drug shortages: a complex healthcare crisis. Mayo Clinical Proc. 89(3):361–373.Crossref, Google Scholar
• Frésard L , Valta P (2016) How does corporate investment respond to increased entry threat? Rev. Corporate Finance Stud. 5(1):1–35.Crossref, Google Scholar
• Gatesman ML , Smith TJ (2011) The shortage of essential chemotherapy drugs in the united states. New England J. Medicine 365(18):1653–1655.Crossref, Google Scholar
• Gershkovich E (2020) ‘People could lose their lives’: Medicine shortages in Russia have left patients fending for themselves. Moscow Times (February 12), https://themoscowtimes.com/2020/02/12/people-could-lose-their-lives-medicine-shortages-in-russia-have-left-patients-fending-for-themselves-a69243.Google Scholar
• Grabowski HG , Vernon JM (1992) Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act. J. Law Econom. 35(2):331–350.Crossref, Google Scholar
• Graham JR , Michaely R , Roberts MR (2003) Do price discreteness and transactions costs affect stock returns? Comparing ex-dividend pricing before and after decimalization. J. Finance 58(6):2611–2635.Crossref, Google Scholar
• Harrington W (2019) A dire scarcity of drugs is worsening, in part, because they are so cheap. Economist (September 14), https://www.economist.com/international/2019/09/14/a-dire-scarcity-of-drugs-is-worsening-in-part-because-they-are-so-cheap.Google Scholar
• Heads of Medicines Agencies (2019) Guidance on detection and notification of shortages of medicinal products for Marketing Authorisation Holders (MAHs) in the Union (EEA). Report, European Medicines Agency, Amsterdam. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guidance-detection-notification-shortages-medicinal-products-marketing-authorisation-holders-mahs_en.pdf.Google Scholar
• Hu X , Gurnani H , Wang L (2013) Managing risk of supply disruptions: Incentives for capacity restoration. Production Oper. Management 22(1):137–150.Crossref, Google Scholar
• Iacus SM , King G , Porro G (2012) Causal inference without balance checking: Coarsened exact matching. Political Anal. 20(1):1–24.Crossref, Google Scholar
• International Society for Pharmaceutical Engineering (2013) Report on the ISPE Drug Shortages Survey. Technical report, International Society for Pharmaceutical Engineering, North Bethesda, MD. https://ispe.org/sites/default/files/initiatives/drug-shortages/2013-ISPE-drug-shortages-survey-report.pdf.Google Scholar
• Iyer AV , Deshpande V , Wu Z (2005) Contingency management under asymmetric information. Oper. Res. Lett. 33(6):572–580.Crossref, Google Scholar
• Jia J , Zhao H (2017) Mitigating the us drug shortages through pareto-improving contracts. Production Oper. Management 26(8):1463–1480.Crossref, Google Scholar
• Kaiser J (2011) Shortages of cancer drugs put patients, trials at risk. Sci. 332(6029):523–523.Google Scholar
• Khanna N , Tice S (2000) Strategic responses of incumbents to new entry: The effect of ownership structure, capital structure, and focus. Rev. Financial Stud. 13(3):749–779.Crossref, Google Scholar
• Khwaja A , Mian A (2008) Tracing the impact of bank liquidity shocks: Evidence from an emerging market. Amer. Econom. Rev. 98(4):1413–1442.Crossref, Google Scholar
• Kim SH , Scott Morton F (2015) A model of generic drug shortages: Supply disruptions, demand substitution, and price control. Working paper, Yale University, New Haven, CT.Google Scholar
• Kim SH , Tomlin B (2013) Guilt by association: Strategic failure prevention and recovery capacity investments. Management Sci. 59(7):1631–1649.Link, Google Scholar
• King G , Nielsen R (2019) Why propensity scores should not be used for matching. Political Anal. 27(4):435–454.Crossref, Google Scholar
• Krishnan V , Maki KM , Castillo EM , Guss DA (2015) Service design for improved satisfaction: Decoding the mechanism for impact of patient callback in emergency healthcare. Service Sci. 7(4):315–330.Link, Google Scholar
• Lee HS , Kesavan S , Deshpande V (2020) Managing the impact of fitting-room traffic on retail sales: Using labor to reduce phantom stockouts. Manufacturing Service Oper. Management , ePub ahead of print August 17, https://doi.org/10.1287/msom.2020.0884 .Link, Google Scholar
• Levine D , Toffel M (2010) Quality management and job quality: How the ISO 9001 standard for quality management systems affects employees and employers. Management Sci. 56(6):978–996.Link, Google Scholar
• Li J , Netessine S (2020) Higher market thickness reduces matching rate in online platforms: Evidence from a quasiexperiment. Management Sci. 66(1):271–289.Link, Google Scholar
• Reibstein DJ , Farris PW (1995) Market share and distribution: A generalization, a speculation, and some implications. Marketing Sci. 14(3_supplement):G190–G202.Google Scholar
• Reiffen D , Ward MR (2005) Generic drug industry dynamics. Rev. Econom. Statist. 87(1):37–49.Crossref, Google Scholar
• Ripollone JE , Huybrechts KF , Rothman KJ , Ferguson RE , Franklin JM (2020) Evaluating the utility of coarsened exact matching for pharmacoepidemiology using real and simulated claims data. Amer. J. Epidemiolology 189(6):613–622.Crossref, Google Scholar
• Roberts MR , Whited TM (2013) Endogeneity in empirical corporate finance. Constantinides GM, Harris M, Stulz RM, eds. Handbook of the Economics of Finance , vol. 2, part A (Elsevier, Amsterdam), 493–572.Crossref, Google Scholar
• Scott Morton FM (1999) Entry decisions in the generic pharmaceutical industry. RAND J. Econom. 30(3):421–440.Crossref, Google Scholar
• Taneri N , De Meyer A (2017) Contract theory: Impact on biopharmaceutical alliance structure and performance. Manufacturing Service Oper. Management 19(3):453–471.Link, Google Scholar
• Thomas K (2020) First drug shortage caused by coronavirus, F.D.A. says. But it won’t disclose what drug or where it’s made. New York Times (February 28), https://www.nytimes.com/2020/02/28/health/drug-coronavirus-shortage.html.Google Scholar
• Throckmorton DC (2018) Federal Efforts to Prevent Drug Shortages An FDA Perspective. Report, Duke Margolis Center for Health Policy, Washington, DC.Google Scholar
• Tomlin B (2006) On the value of mitigation and contingency strategies for managing supply chain disruption risks. Management Sci. 52(5):639–657.Link, Google Scholar
• Tucker EL , Daskin MS , Sweet BV , Hopp WJ (2020) Incentivizing resilient supply chain design to prevent drug shortages: Policy analysis using two-and multi-stage stochastic programs. IISE Trans. 52(4):394–412.Crossref, Google Scholar
• U.S. Food and Drug Administration (2011) A review of FDA’s approach to medical product shortages. FDA Report, U.S. Food and Drug Administration, Silver Spring, MD.Google Scholar
• U.S. Food and Drug Administration (2013) Strategic plan for preventing and mitigating drug shortages. FDA Report, U.S. Food and Drug Administration, Silver Spring, MD. https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM372566.pdf.Google Scholar
• U.S. Government Accountability Office (2014) Drug shortages: Public health threat continues, despite efforts to help ensure product availability. GAO Report GAO-14-194, U.S. Government Accountability Office, Washington, DC.Google Scholar
• Woodcock J , Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clinical Pharmacological 93(2):170–176.Google Scholar
• Yang C , Wu L , Cai W , Zhu W , Shen Q , Li Z , Fang Y (2016) Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: A qualitative study. PLoS One 11(10):e0165183.Crossref, Google Scholar
• Yang Z , Aydın G , Babich V , Beil DR (2012) Using a dual-sourcing option in the presence of asymmetric information about supplier reliability: Competition vs. diversification. Manufacturing Service Oper. Management 14(2):202–217.Link, Google Scholar
• Yurukoglu A , Liebman E , Ridley DB (2017) The role of government reimbursement in drug shortages. Amer. Econom. J. Econom. Policy 9(2):348–382.Crossref, Google Scholar